Home/ Author / Drew Meredith
    Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

  • All Categories

  • All Categories

  • Opinion

  • News

  • SMSFs

  • Leaders

  • Investing 101

  • TO BE RECATEGORIZED

  • Daily Market Update

  • Investing

  • ASX

  • Global

  • Regulation

  • Markets

  • Asset allocation

  • Economics

  • Retirement

  • Growth

  • Advice

  • ESG

  • ETFs

Drew Meredith

Publishing Editor

Drew is publisher of the Inside Network's mastheads and a principal adviser at Wattle Partners.

Drew Meredith results

Commercial property’s defensive qualities missing

Australian real estate investment trusts (REITs), often considered a defensive component in a portfolio, suffered the biggest fall of any asset class in March, according to Morningstar’s review of returns for the month.

Drew Meredith | 14th Apr 2020 | More
The Inside Investor Market Update – April 14th

Australian oil stocks including Woodside Petroleum Ltd (ASX: WPL), Santos Ltd (ASX: STO) and Oil Search Limited (ASX: OSH) will rebound.

Drew Meredith | 14th Apr 2020 | More
A hidden ASX gem: RPMGlobal Holdings

In my opinion, RPMGlobal Holdings Ltd (ASX: RUL) is a hidden ASX small-cap share worthy of your attention.

Drew Meredith | 14th Apr 2020 | More
Why I invested in Xero (ASX:XRO) shares

I know it’s not very professional – nor profitable – to fall in the love with a company, even if the performance of the Xero Limited (ASX: XRO) share price still manages to bring a tear to this shareholder’s eye…

Drew Meredith | 13th Apr 2020 | More
CSL: A true global leader

In the latest of our never sell stocks, is one of Australia’s true global leaders, CSL, or Commonwealth Serum Laboratories. The company was founded in 1916 and was actually part of the Federal Government at the time. CSL is a biopharmaceutical company that researches, develops, manufactures and markets products to treat and prevent human medical…

Drew Meredith | 7th Apr 2020 | More
  • Reconsidering asset allocation

    This is not the time to make bold statements. We can test the water on which asset class is now relatively (noting that phrase) attractive, but inevitably hedge the bet on the possibility things will not be as anticipated. Valuations are in fresh air. We don’t know what earnings might look like, nor is the…

    Drew Meredith | 7th Apr 2020 | More
    Tenancy issues a concern for SMSFs

    The Government is urging the owners of commercial property to work out arrangements with tenants whose businesses are struggling as a result of the COVID-19 crisis. But for trustees of self-managed super fund that own property, there are added complications; that is because their tenants are often related parties. A common financial planning strategy is…

    Drew Meredith | 7th Apr 2020 | More
    Credit funds: take a good look under the bonnet

    Investors in ASX-listed credit funds, which have been very popular with investors looking for yield, are on a steep learning curve right now, as they find that different funds invest in a variety of different assets, with some very different outcomes. While the asset values of some credit funds held up in the face of…

    Drew Meredith | 7th Apr 2020 | More
    Guidance: The silence is deafening

    The uncertainty in equity markets is prompting listed companies to withdraw their earnings guidance. But analysts are calling on a number of companies who have not provided updates to assist investors by giving a clear outlook. Around 34 per cent of the ASX 100 and 25 per cent of the stocks in the Small Ordinaries…

    Drew Meredith | 7th Apr 2020 | More
    Volatility must settle before it’s safe to re-enter market

    There’s a lot of emotion – mainly fear – surrounding the share market at the moment. But for the clients of mechanical rules-based trading system Share Wealth Systems, all that has been taken away. Instead, SWS clients are waiting for an entry signal to get back into the share market. “It’s a simple matter of…

    Drew Meredith | 6th Apr 2020 | More
    Our Authors
    Popular